Terms: = Prostate cancer AND LDH AND Prognosis
35 results:
1. A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model.
Qiu R; Bu K; An H; Tao N
PeerJ; 2023; 11():e16158. PubMed ID: 37818332
[TBL] [Abstract] [Full Text] [Related]
2. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.
Yamada Y; Sakamoto S; Sato K; Saito S; Kanesaka M; Rii J; Kurokawa K; Tachiwaki D; Fukui Y; Shibata H; Goto Y; Sazuka T; Imamura Y; Nakatsu H; Ichikawa T
Prostate; 2023 Dec; 83(16):1610-1618. PubMed ID: 37690087
[TBL] [Abstract] [Full Text] [Related]
3. Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy.
Saito S; Sakamoto S; Higuchi K; Sato K; Zhao X; Wakai K; Kanesaka M; Kamada S; Takeuchi N; Sazuka T; Imamura Y; Anzai N; Ichikawa T; Kawakami E
Sci Rep; 2023 Apr; 13(1):6325. PubMed ID: 37072487
[TBL] [Abstract] [Full Text] [Related]
4. [OVERALL SURVIVAL EVALUATION OF prostate cancer PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY BY ESTIMATING FLUCTUANT PATTERNS OF METABOLIC FACTOR SERUM LEVELS].
Shimabukuro T; Ohmi C; Baba C; Shiraishi K
Nihon Hinyokika Gakkai Zasshi; 2022; 113(1):1-11. PubMed ID: 36682805
[TBL] [Abstract] [Full Text] [Related]
5. [Prostatic Lymphoma: a rare cause of urinary retention (a case report)].
Namaoui RY; Benremouga MC; Boutoura S; Rahali MC; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
Pan Afr Med J; 2022; 43():33. PubMed ID: 36505021
[TBL] [Abstract] [Full Text] [Related]
6. Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant prostate cancer.
Zhu S; Ni Y; Wang Z; Zhang X; Zhang Y; Zhao F; Dai J; Wang Z; Zhu X; Chen J; Zhao J; Zeng Y; Chen N; Zeng P; Shen P; Sun G; Zeng H
Oncologist; 2022 Nov; 27(11):e870-e877. PubMed ID: 36067250
[TBL] [Abstract] [Full Text] [Related]
7. Physodic acid sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosis.
Cardile V; Graziano ACE; Avola R; Madrid A; Russo A
Toxicol In Vitro; 2022 Oct; 84():105432. PubMed ID: 35809792
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
Poteska R; Rahbar K; Semjonow A; Schrader AJ; Boegemann M; Schlack K
BMC Cancer; 2022 Apr; 22(1):375. PubMed ID: 35395766
[TBL] [Abstract] [Full Text] [Related]
9. Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Beyer J; Collette L; Sauvé N; Daugaard G; Feldman DR; Tandstad T; Tryakin A; Stahl O; Gonzalez-Billalabeitia E; De Giorgi U; Culine S; de Wit R; Hansen AR; Bebek M; Terbuch A; Albany C; Hentrich M; Gietema JA; Negaard H; Huddart RA; Lorch A; Cafferty FH; Heng DYC; Sweeney CJ; Winquist E; Chovanec M; Fankhauser C; Stark D; Grimison P; Necchi A; Tran B; Heidenreich A; Shamash J; Sternberg CN; Vaughn DJ; Duran I; Bokemeyer C; Patrikidou A; Cathomas R; Assele S; Gillessen S;
J Clin Oncol; 2021 May; 39(14):1553-1562. PubMed ID: 33729863
[TBL] [Abstract] [Full Text] [Related]
10. Inflammatory markers as prognostic factors in metastatic castration-resistant prostate cancer.
Donate-Moreno MJ; Lorenzo-Sánchez MV; Díaz de Mera-Sánchez Migallón I; Herraiz-Raya L; Esper-Rueda JA; Legido-Gómez O; Rico-Marco S; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2020 Dec; 44(10):692-700. PubMed ID: 33010988
[TBL] [Abstract] [Full Text] [Related]
11. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
12. Association between lactate dehydrogenase levels and oncologic outcomes in metastatic prostate cancer: A meta-analysis.
Li F; Xiang H; Pang Z; Chen Z; Dai J; Chen S; Xu B; Zhang T
Cancer Med; 2020 Oct; 9(19):7341-7351. PubMed ID: 32452656
[TBL] [Abstract] [Full Text] [Related]
13. ARNT-dependent CCR8 reprogrammed ldh isoform expression correlates with poor clinical outcomes of prostate cancer.
Chen G; Cai ZD; Lin ZY; Wang C; Liang YX; Han ZD; He HC; Mo RJ; Lu JM; Pan B; Wu CL; Wang F; Zhong WD
Mol Carcinog; 2020 Aug; 59(8):897-907. PubMed ID: 32319143
[TBL] [Abstract] [Full Text] [Related]
14. The value of tumor markers in men with metastatic prostate cancer undergoing [
Yordanova A; Linden P; Hauser S; Feldmann G; Brossart P; Fimmers R; Essler M; Holdenrieder S; Ahmadzadehfar H
Prostate; 2020 Jan; 80(1):17-27. PubMed ID: 31579967
[TBL] [Abstract] [Full Text] [Related]
15. Relationship between serum markers and volume of liver metastases in castration-resistant prostate cancer.
Ranasinghe L; Cotogno P; Ledet E; Bordlee B; Degeyter K; Nguyen N; Steinberger A; Manogue C; Barata P; Lewis BE; Sartor AO
Cancer Treat Res Commun; 2019; 20():100151. PubMed ID: 31128516
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive prostate cancer.
Miyake H; Matsushita Y; Watanabe H; Tamura K; Motoyama D; Ito T; Sugiyama T; Otsuka A
Anticancer Res; 2019 Mar; 39(3):1391-1396. PubMed ID: 30842173
[TBL] [Abstract] [Full Text] [Related]
17. Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.
Okamoto T; Hatakeyama S; Narita S; Takahashi M; Sakurai T; Kawamura S; Hoshi S; Ishida M; Kawaguchi T; Ishidoya S; Shimoda J; Sato H; Mitsuzuka K; Tochigi T; Tsuchiya N; Arai Y; Habuchi T; Ohyama C
World J Urol; 2019 Sep; 37(9):1827-1835. PubMed ID: 30511214
[TBL] [Abstract] [Full Text] [Related]
18. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting.
Oh WK; Cheng WY; Miao R; Vekeman F; Gauthier-Loiselle M; Duh MS; Drea E; Szatrowski TP
Urol Oncol; 2018 Nov; 36(11):500.e1-500.e9. PubMed ID: 30201382
[TBL] [Abstract] [Full Text] [Related]
19. Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant prostate cancer.
Cotogno PM; Ranasinghe LK; Ledet EM; Lewis BE; Sartor O
Oncologist; 2018 Jul; 23(7):791-797. PubMed ID: 29700205
[TBL] [Abstract] [Full Text] [Related]
20. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
Liu L; He Y; Ge G; Li L; Zhou P; Zhu Y; Tang H; Huang Y; Li W; Zhang L
PLoS One; 2017; 12(8):e0182168. PubMed ID: 28767733
[TBL] [Abstract] [Full Text] [Related]
[Next]
